15 Results for "

CDI

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "CDI" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-17580
CAS No.: 873857-62-6
Synonyms: OPT-80; PAR-101
Fidaxomicin (OPT-80), a macrocyclic antibiotic, is an orally active and potent RNA polymerase inhibitor. Fidaxomicin has a narrow spectrum of antibacterial activity and a good anti-Clostridium difficile activity (MIC90=0.12 μg/mL). Fidaxomicin can be used for Clostridium difficile infection (CDI) research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-128357
CAS No.: 1275582-97-2
Purity:  ≥98.0%
Synonyms: ACX-362E; GLS-362E
Research Areas:  

Infection

Ibezapolstat (ACX-362E) is a first-in-class, orally active DNA polymerase IIIC (pol IIIC) inhibitor, with a Ki of 0.325 μM for the DNA pol IIIC from C. difficile. Ibezapolstat is developed for the research of C. difficile infection(CDI) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9929
CAS No.: 1246264-45-8
Synonyms: BLA761046; MBL-CDB1; MDX-1388

Target:  

Bacterial

Research Areas:  

Infection

Bezlotoxumab (BLA761046; MBL-CDB1; MDX-1388) is a fully humanized IgG1/kappa monoclonal antibody directed against Clostridium difficile toxin B. Bezlotoxumab mediates the early reconstitution of gut microbiota to reduce the risk of recurrent Clostridium difficile infection (CDI). Bezlotoxumab can be used for the study of recurrent Clostridium difficile infection prevention .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-115440
CAS No.: 1013915-99-5
Purity:  99.18%
Synonyms: REP-3123 dihydrochloride
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

CRS3123 (REP-3123) dihydrochloride, a fully synthetic antibacterial agent, potently inhibits methionyl-tRNA synthetase (MetRS) of Clostridioides difficile, inhibiting Clostridioides difficile toxin production and spore formation. CRS3123 dihydrochloride is an oral agent for the research of Clostridioides difficile infection (CDI) .
loading...
    loading...
Cat. No.: HY-17580R
CAS No.: 873857-62-6
Synonyms: OPT-80 (Standard); PAR-101 (Standard)
Fidaxomicin (Standard) is the analytical standard of Fidaxomicin. This product is intended for research and analytical applications. Fidaxomicin (OPT-80), a macrocyclic antibiotic, is an orally active and potent RNA polymerase inhibitor. Fidaxomicin has a narrow spectrum of antibacterial activity and a good anti-Clostridium difficile activity (MIC90=0.12 μg/mL). Fidaxomicin can be used for Clostridium difficile infection (CDI) research .
loading...
    loading...
Cat. No.: HY-148578
CAS No.: 2924055-46-7
Purity:  99.03%
Target:  

Bacterial

Research Areas:  

Infection

CamA-IN-1 is a Clostridioides difficile-specific DNA adenine methyltransferase (CamA) inhibitor. CamA-IN-1 has inhibitory for CamA with IC50 and Kd values of 0.4 μM and 0.2 μM, respectively. CamA-IN-1 can be used for the research of Clostridioides difficile infections (CDI) .
loading...
    loading...
Cat. No.: HY-128357A
CAS No.: 1275582-98-3
Synonyms: ACX-362E hydrochloride; GLS-362E hydrochloride
Research Areas:  

Infection

Ibezapolstat hydrochloride is a first-in-class, orally active DNA polymerase IIIC (pol IIIC) inhibitor, with a Ki of 0.325 μM for the DNA pol IIIC from C. difficile. Ibezapolstat hydrochloride is developed for the research of C. difficile infection(CDI) .
loading...
    loading...
Cat. No.: HY-156282
CAS No.: 2804045-21-2
Target:  

Bacterial

Research Areas:  

Infection

Antibacterial agent 158 (compound 6c), a Micrococcin analogue, and is effective against impetigo and C. difficile infection (CDI) .
loading...
    loading...
Cat. No.: HY-172768
CAS No.: 2930140-57-9
Target:  

Bacterial

Research Areas:  

Infection

SCUT1-2 is a bifunctional antibacterial agent with good oral bioavailability in mice (F=56.8%). SCUT1-2 can kill the vegetative cells of C. difficile with a MIC of 0.06-0.50 μg/mL, and inhibit spore germination in vitro. SCUT1-2 could alleviate the symptoms of weight loss and diarrhea in mice caused by C. difficile infection (CDI) and prevent recurrent CDI .
loading...
    loading...
Cat. No.: HY-156283
CAS No.: 2804044-53-7
Target:  

Antibiotic

Research Areas:  

Infection

Antibacterial agent 159 (Compound 6d) is an antibiotic. Antibacterial agent 159 can effective against impetigo and C. difficile infection (CDI). Antibacterial agent 159 has no observed recurrence for C. difficile and exertes a minimal impact on the beneficial gut microbiome .
loading...
    loading...
Cat. No.: HY-157257
CAS No.: 1546799-45-4
Research Areas:  

Others

Trimethoprim fumaric acid (Compound CDI) is a universal hapten for ASGs (Antibacterial synergists) and can be used to design broadly specific monoclonal antibodies (mAbs) against ASGs. The mAb developed by Trimethoprim fumaric acid can be applied in ELISA to detect the residues of ASGs in foods of animal origin .
loading...
    loading...
Cat. No.: HY-P702958
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDI1; CIP2; KAP
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P88249
Synonyms: CDI1; CIP2; KAP; KAP1

Host:  

Mouse

Application:  

IHC-P, ICC/IF, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P88249A
Synonyms: CDI1; CIP2; KAP; KAP1

Host:  

Mouse

Application:  

IHC-P, ICC/IF, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-17580S1
Synonyms: OPT-80-d6; PAR-101-d6
Fidaxomicin-d6 (OPT-80-d6) is the deuterium labeled Fidaxomicin (HY-17580). Fidaxomicin (OPT-80), a macrocyclic antibiotic, is an orally active and potent RNA polymerase inhibitor. Fidaxomicin has a narrow spectrum of antibacterial activity and a good anti-Clostridium difficile activity (MIC90=0.12 μg/mL). Fidaxomicin can be used for Clostridium difficile infection (CDI) research .
loading...
    loading...
  • 1